Related Experiment Video
Updated: Feb 12, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Hypertension
Suzanne Oparil1, Maria Czarina Acelajado2, George L Bakris3
1Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, Department of Medicine, School of Medicine, The University of Alabama at Birmingham (UAB), 1720 2nd Avenue South, Birmingham, AL, 35294-0007, USA.
Insights
Systemic arterial hypertension is a major global health risk. Effective management through lifestyle changes and medication significantly reduces cardiovascular disease (CVD) risks and mortality.
Area of Science:
- Internal Medicine
- Cardiology
- Public Health
Background:
- Systemic arterial hypertension is a leading modifiable risk factor for global morbidity and mortality.
- Hypertension significantly increases the risk of cardiovascular disease (CVD), yet awareness and treatment rates remain suboptimal.
- The development of hypertension stems from a complex interaction between environmental, pathophysiological, and genetic factors.
Purpose of the Study:
- To outline the significance of hypertension as a public health issue.
- To detail the comprehensive evaluation process for hypertensive patients.
- To emphasize the importance of lifestyle modifications and pharmacological treatments in managing hypertension and preventing CVD.
Main Methods:
- Standardized blood pressure (BP) measurement.
- Assessment of atherosclerotic CVD risk and target-organ damage.
- Screening for secondary causes of hypertension and comorbidities.
- Evaluation of lifestyle interventions (diet, physical activity).
- Review of first-line pharmacological therapies.
Main Results:
- Successful hypertension treatment demonstrably reduces global disease burden and mortality.
- Lifestyle modifications are effective in lowering BP and preventing hypertension-related CVD.
- Pharmacological therapies, including ACE inhibitors, ARBs, CCBs, and thiazide diuretics, are highly effective in lowering BP and preventing CVD outcomes.
Conclusions:
- Hypertension management is critical for reducing all-cause mortality and morbidity.
- A multi-faceted approach combining lifestyle changes and pharmacotherapy is essential for effective hypertension control.
- Early detection and adequate treatment of hypertension are key to mitigating its severe cardiovascular consequences.
Abstract:
Systemic arterial hypertension is the most important modifiable risk factor for all-cause morbidity and mortality worldwide and is associated with an increased risk of cardiovascular disease (CVD). Fewer than half of those with hypertension are aware of their condition, and many others are aware but not treated or inadequately treated, although successful treatment of hypertension reduces the global burden of disease and mortality. The aetiology of hypertension involves the complex interplay of environmental and pathophysiological factors that affect multiple systems, as well as genetic predisposition. The evaluation of patients with hypertension includes accurate standardized blood pressure (BP) measurement, assessment of the patients' predicted risk of atherosclerotic CVD and evidence of target-organ damage, and detection of secondary causes of hypertension and presence of comorbidities (such as CVD and kidney disease). Lifestyle changes, including dietary modifications and increased physical activity, are effective in lowering BP and preventing hypertension and its CVD sequelae. Pharmacological therapy is very effective in lowering BP and in preventing CVD outcomes in most patients; first-line antihypertensive medications include angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, dihydropyridine calcium-channel blockers and thiazide diuretics.
Related Concept Videos
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Hypertension III: Clinical Manifestations and Diagnostic Studies

